Explanipedia

Environmental justice index and prevalence of asthma and COPD in US neighborhoods- a population-based study Open

Sumanth Khadke, Vidhatri Khadke, Ashish Kumar, Bhargav Makwana, Sourbha S. Dani , et al. · 2025

None.

Predictors of Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry Open

Hyun Joo Kim, Jeremy M. Weber, Megan L. Neely, Amy Hajari Case, A. Jbeli , et al. · 2025

P-1900. Temporal Course and Risk Factors of Coinfections in Patients Hospitalized for COVID-19 Open

James L Vilkas, A Akmal, Arslan Sarwar, Yuxiu Lei, Timothy Liesching · 2025

Background Studies about the distinction between coinfections acquired prior to admission and hospital-acquired coinfections and risk factors at different time point are limited. Methods We reviewed microbiology laboratory data of patients…

Lung function trajectories in patients with idiopathic pulmonary fibrosis Open

Megan L. Neely, Anne S. Hellkamp, Shaun Bender, Jamie L. Todd, Timothy Liesching , et al. · 2023

Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterised by decline in lung function. We evaluated trajectories of forced vital capacity (FVC) and diffusing capacity (DLco) in a coho…

Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis Open

João A. de Andrade, Megan L. Neely, Anne S. Hellkamp, Daniel A. Culver, Hyun J. Kim , et al. · 2023

Analyses based on causal inference methodology suggest that patients with IPF who receive antifibrotic therapy have improved survival.

Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis Open

Avignat S. Patel, Ezra R. Miller, Shawn M. Regis, Gary M. Hunninghake, Lori Lyn Price , et al. · 2023

Racial Difference in Hospital and Critical Care Admissions and Mortality before and during the COVID-19 Pandemic Open

Timothy Liesching, Yuxiu Lei · 2022

Purpose: To explore the racial difference in hospital and intensive critical care (ICU) admissions and mortality during COVID-19 pandemic compared to the pre-COVID period. Methods: This was a retrospective observational study.

Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry Open

Aparna Swaminathan, Anne S. Hellkamp, Megan L. Neely, Shaun Bender, Luca Paoletti , et al. · 2022

Rationale: Lung transplant offers the potential to extend life for patients with idiopathic pulmonary fibrosis (IPF); yet, this therapeutic modality is only available to a small proportion of patients. Objectives: To identify…

Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry Open

João A. de Andrade, Tejaswini Kulkarni, Megan L. Neely, Anne S. Hellkamp, Amy Hajari Case , et al. · 2022

Effect of Antifibrotic Therapy on Survival in Patients with Idiopathic Pulmonary Fibrosis Open

Joao Alberto de Andrade, Megan L. Neely, Anne S. Hellkamp, Daniel A. Culver, Han Jo Kim , et al. · 2022

Hospitalizations in patients with idiopathic pulmonary fibrosis Open

Hyun J. Kim, Laurie D. Snyder, Ayodeji Adegunsoye, Megan L. Neely, Shaun Bender , et al. · 2021

Qualitative coronary artery calcification scores and risk of all cause, COPD and pneumonia hospital admission in a large CT lung cancer screening cohort Open

Lee Gazourian, Shawn M. Regis, Elizabeth J. Pagura, Lori Lyn Price, Melissa Gawlik , et al. · 2021

The effect of a tiered provider staffing model on patient outcomes during the coronavirus disease 2019 pandemic Open

James Dargin, Susan Stempek, Yuxiu Lei, Anthony Gray, Timothy Liesching · 2021

Background: During the coronavirus disease 2019 (COVID-19) pandemic, our hospital experienced a large influx of critically ill patients with acute respiratory failure. In order to increase intensive care unit (ICU) surge capacity, we adopt…

Characteristics and outcomes of patients receiving high flow nasal cannula therapy prior to mechanical ventilation in COVID-19 respiratory failure Open

Christopher K. Hansen, Susan Stempek, Timothy Liesching, Yuxiu Lei, James Dargin · 2021

Background: Treatment strategies for acute hypoxic respiratory failure secondary to coronavirus 2019 disease (COVID-19) had significant variation early in the pandemic. We sought to determine if patients treated with high flow nasal cannul…

Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study Open

Lee Gazourian, William B. Thedinger, Shawn M. Regis, Elizabeth J. Pagura, Lori Lyn Price , et al. · 2020

Quantitative Pectoralis Muscle Area is Associated with the Development of Lung Cancer in a Large Lung Cancer Screening Cohort Open

Lee Gazourian, Chantal S. Durgana, Devon Huntley, Giulia Rizzo, William B. Thedinger , et al. · 2020

Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry Open

Margaret L. Salisbury, Craig Conoscenti, Daniel A. Culver, Eric Yow, Megan L. Neely , et al. · 2020

Rationale: Two antifibrotic medications, nintedanib and pirfenidone, have been approved for the treatment of idiopathic pulmonary fibrosis (IPF) in the United States. Few data have been published on the use of these medications in c…

Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis Open

Emily C. O’Brien, Anne S. Hellkamp, Megan L. Neely, Aparna Swaminathan, Shaun Bender , et al. · 2020

<i>ERJ</i>Podcast September 2015: Updating the GINA guidelines for asthma control Open

Jean Bousquet, Marc Humbert, Robert Naeije, Anton Vonk Noordegraaf, Gábor Kovács , et al. · 2015

Implementation and outcomes of a medical emergency team (MET) e-learning program Open

Timothy Liesching, Yuxiu Lei · 2015

A randomised trial of lung sealant<i>versus</i>medical therapy for advanced emphysema Open

Carolyn E. Come, Mordechai R. Kramer, Mark T. Dransfield, Muhanned Abu‐Hijleh, David Berkowitz , et al. · 2015

Uncontrolled pilot studies demonstrated promising results of endoscopic lung volume reduction using emphysematous lung sealant (ELS) in patients with advanced, upper lobe predominant emphysema. We aimed to evaluate the safety and efficacy …

Timothy Liesching YOU? Author Swipe